| CD diagnosis, No. | 169a |
| Fistula diagnosis, No. | |
| Patients | 59 |
| Episodes | 88 |
| Fistula episodes/patient, No. (%) | |
| 1 | 39 (66) |
| 2 | 13 (22) |
| ≥3 | 7 (12) |
| Cumulative incidence of fistulizing CD, % | |
| Year 1 after diagnosis | 21.0 |
| Year 5 after diagnosis | 26.0 |
| Year 10 after diagnosis | 33.0 |
| Year 20 after diagnosis | 50.0 |
| Type of fistula, No. (%) | |
| Anal | 48 (55) |
| Rectovaginal | 8 (9) |
| Enterocutaneous | 5 (6) |
| Internalb | 27 (31) |
| CD diagnosis, No. | 169a |
| Fistula diagnosis, No. | |
| Patients | 59 |
| Episodes | 88 |
| Fistula episodes/patient, No. (%) | |
| 1 | 39 (66) |
| 2 | 13 (22) |
| ≥3 | 7 (12) |
| Cumulative incidence of fistulizing CD, % | |
| Year 1 after diagnosis | 21.0 |
| Year 5 after diagnosis | 26.0 |
| Year 10 after diagnosis | 33.0 |
| Year 20 after diagnosis | 50.0 |
| Type of fistula, No. (%) | |
| Anal | 48 (55) |
| Rectovaginal | 8 (9) |
| Enterocutaneous | 5 (6) |
| Internalb | 27 (31) |
aExcludes 6 residents with diagnosis of CD who declined consent.
bIncludes enteroenteric (n = 21), enterovesical (n = 3), and entero-intraabdominal (n = 3).
| CD diagnosis, No. | 169a |
| Fistula diagnosis, No. | |
| Patients | 59 |
| Episodes | 88 |
| Fistula episodes/patient, No. (%) | |
| 1 | 39 (66) |
| 2 | 13 (22) |
| ≥3 | 7 (12) |
| Cumulative incidence of fistulizing CD, % | |
| Year 1 after diagnosis | 21.0 |
| Year 5 after diagnosis | 26.0 |
| Year 10 after diagnosis | 33.0 |
| Year 20 after diagnosis | 50.0 |
| Type of fistula, No. (%) | |
| Anal | 48 (55) |
| Rectovaginal | 8 (9) |
| Enterocutaneous | 5 (6) |
| Internalb | 27 (31) |
| CD diagnosis, No. | 169a |
| Fistula diagnosis, No. | |
| Patients | 59 |
| Episodes | 88 |
| Fistula episodes/patient, No. (%) | |
| 1 | 39 (66) |
| 2 | 13 (22) |
| ≥3 | 7 (12) |
| Cumulative incidence of fistulizing CD, % | |
| Year 1 after diagnosis | 21.0 |
| Year 5 after diagnosis | 26.0 |
| Year 10 after diagnosis | 33.0 |
| Year 20 after diagnosis | 50.0 |
| Type of fistula, No. (%) | |
| Anal | 48 (55) |
| Rectovaginal | 8 (9) |
| Enterocutaneous | 5 (6) |
| Internalb | 27 (31) |
aExcludes 6 residents with diagnosis of CD who declined consent.
bIncludes enteroenteric (n = 21), enterovesical (n = 3), and entero-intraabdominal (n = 3).
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
